Mesoblast director files Form 3 insider holdings
Mesoblast Ltd director William Murray Burns filed an initial Form 3 showing his beneficial holdings in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Mesoblast Ltd director William Murray Burns filed an initial Form 3 showing his beneficial holdings in the company. The filing lists several option awards over Ordinary Shares with exercise prices ranging from $0.36 to $1.81 per share and expirations between 2026 and 2031. It also reports direct ownership of 226,250 Ordinary Shares as of the reporting date. These entries reflect existing positions rather than new purchases or sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Option (right to buy) | -- | -- | -- |
| Holding | Option (right to buy) | -- | -- | -- |
| Holding | Option (right to buy) | -- | -- | -- |
| Holding | Option (right to buy) | -- | -- | -- |
| Holding | Option (right to buy) | -- | -- | -- |
| Holding | Option (right to buy) | -- | -- | -- |
| Holding | Option (right to buy) | -- | -- | -- |
| Holding | Option (right to buy) | -- | -- | -- |
| Holding | Option (right to buy) | -- | -- | -- |
| Holding | Ordinary Shares | -- | -- | -- |
Key Figures
Key Terms
Form 3 regulatory
Option (right to buy financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Mesoblast (MESO) Form 3 filing by William Murray Burns show?
Do the Mesoblast (MESO) Form 3 entries show any insider buying or selling?
What are the key expiration dates for William Murray Burns’ Mesoblast (MESO) options?
AI-generated analysis. How Rhea-AI works. Not financial advice.
